GT200100111A - Derivados de pirrol - Google Patents
Derivados de pirrolInfo
- Publication number
- GT200100111A GT200100111A GT200100111A GT200100111A GT200100111A GT 200100111 A GT200100111 A GT 200100111A GT 200100111 A GT200100111 A GT 200100111A GT 200100111 A GT200100111 A GT 200100111A GT 200100111 A GT200100111 A GT 200100111A
- Authority
- GT
- Guatemala
- Prior art keywords
- compounds
- pirrol
- derivatives
- pirrol derivatives
- virica
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A NUEVOS DERIVADOS DE PIRROL, UN PROCESO PARA SU FABRICACION, COMPOSICIONES FARMACEUTICAS Y EL USO DE TALES COMPUESTOS EN MEDICINA. EN PARTICULAR, LOS COMPUESTOS QUE SON INHIBIDORES DE LA ENZIMA TRANSCRIPTASA INVERSA DEL VIRUS DE LA INMUNODEFICIENCIA HUMANA, QUE ESTA IMPLICADO EN LA REPLICACION DEL VIRICA. EN CONSECUENCIA, LOS COMPUESTOS DE ESTA INVENCION PUEDEN UTILIZARSE VENTAJOSAMENTE COMO AGENTES TERAPEUTICOS PARA EL PROCESO MEDIADO POR EL VIH. ESTOS COMPUESTOS ESTAN REPRESENTADDOS POR LA FORMULA QUIMICA (I) EN DONDE R1, R2, R3, R4, R5 Y X SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0016453.3A GB0016453D0 (en) | 2000-07-04 | 2000-07-04 | Pyrrole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200100111A true GT200100111A (es) | 2002-03-18 |
Family
ID=9895031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200100111A GT200100111A (es) | 2000-07-04 | 2001-06-12 | Derivados de pirrol |
Country Status (17)
Country | Link |
---|---|
US (1) | US6737429B2 (es) |
EP (1) | EP1301481A1 (es) |
JP (1) | JP2004502674A (es) |
KR (1) | KR100549884B1 (es) |
CN (1) | CN1440385A (es) |
AR (1) | AR028602A1 (es) |
AU (2) | AU6387401A (es) |
BR (1) | BR0112241A (es) |
CA (1) | CA2412270A1 (es) |
EC (1) | ECSP014109A (es) |
GB (1) | GB0016453D0 (es) |
GT (1) | GT200100111A (es) |
MX (1) | MXPA02012409A (es) |
PA (1) | PA8516201A1 (es) |
PE (1) | PE20020269A1 (es) |
UY (1) | UY26720A1 (es) |
WO (1) | WO2002002524A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1405849A1 (en) * | 2002-10-04 | 2004-04-07 | Corning Incorporated | Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom |
DK2666481T3 (en) | 2003-12-26 | 2019-02-25 | Masatoshi Hagiwara | A method for regulating the phosphorylation of SR protein and antiviral agents comprising an SR protein activity regulator as the active ingredient |
WO2006036024A1 (ja) | 2004-09-30 | 2006-04-06 | Takeda Pharmaceutical Company Limited | プロトンポンプ阻害薬 |
TW200628446A (en) * | 2004-12-14 | 2006-08-16 | Takeda Pharmaceuticals Co | Substituted pyrrole derivative |
US20080176919A1 (en) * | 2005-01-06 | 2008-07-24 | Pfizer Inc | Imidazole Derivatives As Enzyme Reverse Transcriptase Modulators |
PL1919865T3 (pl) | 2005-08-30 | 2011-09-30 | Takeda Pharmaceuticals Co | 1-heterocyklilosulfonylo, 2-aminometylo, 5-(hetero-) arylo podstawione pochodne 1-h-pirolu jako kwasowe inhibitory wydzielania |
EP2076492A4 (en) * | 2006-10-06 | 2010-12-22 | Merck Sharp & Dohme | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS |
EP2099443A4 (en) * | 2006-11-10 | 2010-05-05 | Syndax Pharmaceuticals Inc | ASSOCIATION OF ERA + LIGANDS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER |
US8933105B2 (en) | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
WO2009015180A2 (en) * | 2007-07-23 | 2009-01-29 | Syndax Pharmaceuticals, Inc. | Novel compounds and methods of using them |
KR101546987B1 (ko) * | 2007-10-16 | 2015-08-24 | 가부시키가이샤 니콘 | 조명 광학 시스템, 노광 장치 및 디바이스 제조 방법 |
US20090131367A1 (en) * | 2007-11-19 | 2009-05-21 | The Regents Of The University Of Colorado | Combinations of HDAC Inhibitors and Proteasome Inhibitors |
CN102197033B (zh) | 2008-08-27 | 2014-07-16 | 武田药品工业株式会社 | 吡咯化合物 |
GB0823001D0 (en) * | 2008-12-17 | 2009-01-28 | Syngenta Participations Ag | Thiophene,furan and pyrrole derivatives with plant growth regulating properties |
CN101775011B (zh) * | 2009-01-13 | 2013-07-31 | 中国人民解放军军事医学科学院毒物药物研究所 | N-取代苯基-3-甲烯杂环芳烃-2,5-二甲基吡咯类化合物及其抗hiv/aids的应用 |
JP2023503062A (ja) * | 2019-11-19 | 2023-01-26 | ニューヨーク ブラッド センター インコーポレイテッド | Hivにおける治療活性を有する置換複素環 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3644631A (en) * | 1969-05-13 | 1972-02-22 | Endo Lab | Therapeutic methods utilizing aryl pyrrol-3-yl ketones |
US4282242A (en) * | 1980-03-07 | 1981-08-04 | Pfizer Inc. | Antidiabetic pyrrolecarboxylic acids |
US4347186A (en) * | 1980-10-20 | 1982-08-31 | Syntex (U.S.A.) Inc. | Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein |
RU2130453C1 (ru) * | 1992-12-17 | 1999-05-20 | Пфайзер Инк. | Замещенные пиразолы, фармацевтическая композиция на их основе, способ лечения, промежуточный продукт |
US5968944A (en) * | 1994-06-06 | 1999-10-19 | Pfizer Inc. | Substituted pyrazoles as corticotropin-releasing factor (CRF) antagonists |
TW406075B (en) * | 1994-12-13 | 2000-09-21 | Upjohn Co | Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds |
AU3044197A (en) * | 1996-07-11 | 1998-02-09 | Pfizer Inc. | Pyridylpyrrole compounds useful as interleukin- and tnf antagonists |
DE19963174A1 (de) * | 1999-12-27 | 2001-07-12 | Gruenenthal Gmbh | Substituierte Pyrrol-Mannichbasen |
-
2000
- 2000-07-04 GB GBGB0016453.3A patent/GB0016453D0/en not_active Ceased
-
2001
- 2001-04-30 AU AU6387401A patent/AU6387401A/xx active Pending
- 2001-04-30 BR BR0112241-0A patent/BR0112241A/pt not_active Withdrawn
- 2001-04-30 JP JP2002507781A patent/JP2004502674A/ja active Pending
- 2001-04-30 CN CN01812290A patent/CN1440385A/zh active Pending
- 2001-04-30 KR KR1020037000138A patent/KR100549884B1/ko not_active IP Right Cessation
- 2001-04-30 AU AU2001263874A patent/AU2001263874B2/en not_active Ceased
- 2001-04-30 MX MXPA02012409A patent/MXPA02012409A/es active IP Right Grant
- 2001-04-30 CA CA002412270A patent/CA2412270A1/en not_active Abandoned
- 2001-04-30 EP EP01938137A patent/EP1301481A1/en not_active Withdrawn
- 2001-04-30 WO PCT/EP2001/004832 patent/WO2002002524A1/en not_active Application Discontinuation
- 2001-05-04 PA PA20018516201A patent/PA8516201A1/es unknown
- 2001-05-18 UY UY26720A patent/UY26720A1/es not_active Application Discontinuation
- 2001-05-22 AR ARP010102414A patent/AR028602A1/es not_active Application Discontinuation
- 2001-05-25 PE PE2001000487A patent/PE20020269A1/es not_active Application Discontinuation
- 2001-06-12 GT GT200100111A patent/GT200100111A/es unknown
- 2001-06-13 US US09/880,534 patent/US6737429B2/en not_active Expired - Fee Related
- 2001-07-04 EC EC2001004109A patent/ECSP014109A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN1440385A (zh) | 2003-09-03 |
AU2001263874B2 (en) | 2006-10-19 |
JP2004502674A (ja) | 2004-01-29 |
MXPA02012409A (es) | 2003-04-25 |
AR028602A1 (es) | 2003-05-14 |
US20020032221A1 (en) | 2002-03-14 |
GB0016453D0 (en) | 2000-08-23 |
AU6387401A (en) | 2002-01-14 |
WO2002002524A1 (en) | 2002-01-10 |
US6737429B2 (en) | 2004-05-18 |
UY26720A1 (es) | 2001-11-30 |
KR20030014321A (ko) | 2003-02-15 |
ECSP014109A (es) | 2002-02-25 |
PA8516201A1 (es) | 2002-07-30 |
CA2412270A1 (en) | 2002-01-10 |
BR0112241A (pt) | 2003-06-24 |
PE20020269A1 (es) | 2002-04-08 |
EP1301481A1 (en) | 2003-04-16 |
KR100549884B1 (ko) | 2006-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200100201A (es) | Derivados de pirazol para el tratamiento der enfermedades viricas. | |
GT200100111A (es) | Derivados de pirrol | |
UY28578A1 (es) | Derivados de amida | |
AR005053A1 (es) | Compuestos de difenilhexano, un procedimiento para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos, y procedmientos para la manufactura de medicamentos para inhibir la infeccion de hiv | |
UY29301A1 (es) | Derivados amida | |
AR055369A1 (es) | Compuestos derivados de xantina, su uso para preparar un medicamento para el tratamiento de una enfermedad mediada por el receptor hm74a, formulaciones y combinacion farmaceuticas que la comprenden y metodo de preparacion de los mismos | |
CR7069A (es) | Derivados de pirazol para el tratamiento de vih | |
SV2002000696A (es) | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgesicos pc9985ahxk/bb | |
AR063602A1 (es) | Derivados de espiroindolinona, formulaciones farmaceuticas que los contienen y su uso en la obtencion de un medicamento para el tratamiento de trastornos oncologicos. | |
PA8446001A1 (es) | Derivados de n-hidroxi-b-sulfonilpropionamida | |
ES2194265T3 (es) | Derivados de piperidino 4-carboxamida y su utilizacion como antagonistas de la neuroquinina. | |
UY29827A1 (es) | 2-amina-pirimidina-4-(2-metil-1-(tetrahidro-2h-piran-4-il)-1-imidazol-5-y1) sustituidas y sus derivados, composiciones farmacéuticas que las contienen, procesos para su preparación y aplicaciones | |
UY28059A1 (es) | Nuevos derivados de dihidropirimido (4,5-d) pirimidona sustituida por amino. fabricacion y uso de los mismos como agentes farmaceuticos. | |
UY28737A1 (es) | Compuestos farmacéuticamente activos | |
UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
ECSP055685A (es) | Nuevos compuestos de isotiazol e isoxazol como inhibidores del factor de crecimiento transformador (tgf) | |
AR049711A1 (es) | Compuestos heterociclicos condensados como inhibidores de la aldosterona sintasa; composiciones farmaceuticas que los contienen y su uso en la preparacion de un medicamento para el tratamiento o prevencion de enfermedades relacionadas con el hiperaldosterismo y por una liberacion excesiva de cortiso | |
CO4810375A1 (es) | Derivados de 9-amino-3-ceto eritromicina | |
GT200100196A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7. | |
PA8568101A1 (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso | |
CO2023000056A2 (es) | Derivados de amidopirimidona | |
UY29739A1 (es) | Derivados de amidas o sales farmacéuticamente aceptables de los mismos, procesos de preparaciones farmacéuticas conteniéndolos y aplicaciones | |
CL2020001817A1 (es) | Moduladores del receptor c5a | |
CL2003002565A1 (es) | Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci | |
CL2022002386A1 (es) | Compuestos de amino pirimidina fusionados |